하지정맥류 치료 시장 규모, 점유율 및 동향 분석 보고서 : 유형별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Varicose Veins Treatment Market Growth & Trends:

The global varicose veins treatment market size is expected to reach USD 2.08 billion by 2030, registering to grow at a CAGR of 6.4% from 2024 to 2030 according to a new report by Grand View Research, Inc. The increasing technological advancements coupled with the increased availability of the advanced varicose vein treatment devices and shift towards less-invasive procedures are the contributing factors for the growth of the market.

The huge burden of vascular diseases in Europe and North America and the increasing patient compliance and reliability, growth in healthcare expenditure, and the rapid growth in geriatric population is majorly driving the varicose vein procedure market.

The upward trend in lifestyle disorders, such as increasing obesity, sleep disorders, blood pressure levels, hormonal changes, genetic disorders and pregnancy are the few major factors contributing to the peripheral vascular diseases. Untreated venous insufficiency, such as varicose vein and venous ulcers cause progressive syndromes including chronic veinous insufficiency. In 2015, according to FutSci, chronic veinous insufficiency is widespread and is a socially isolating condition caused in adults. It is the most common disease in the world and is estimated to affect 5% of the population in the Western countries.

Varicose Veins Treatment Market Report Highlights:

• The sclerotherapy segment was identified as the most profitable procedure owing to the benefits, such as the requirement of minimal incision and reduced scarring, related to the procedure. Moreover,the following advantages: increased penetration, cost and time efficiency, reduced risk of collateral damage to surrounding tissues, fewer post-operative complications, and painless procedure are the main contributors for the growth of this segment.
• The endovenous ablation segment is expected to be the fastest growing segment due to the benefits of short treatment time and improved blood circulation after the procedure. The ClosureFast technique in the endovenous ablation treatment segment has gained momentum due to the minimized side effects, potential cost-saving ability, and better patient outcomes.
• The endovenous chemoablation or chemical sclerosis segment was the most widely used medical procedure among the ablation procedures. Sclerotherapy, intense-pulsed-light therapy, laser ablation, radiofrequency, and ambulatory phlebectomy are the modern techniques that are usedmore oftendue to their less invasive nature.
• In 2023, North America held the largest market share due to the increasing incidence rate of varicose and spider vein in the population, favourable reimbursement policies, increased healthcare awareness, government spending, and the rising aesthetic awareness in the region
• The Asia Pacific is expected to register the fastest growth due to factors, such as the improving healthcare infrastructure, the increase in patient awareness level regarding the benefits of early treatment of the varicose veins, and the rising disposable income
• Some key players of the market include Quanta Systems S.p.A, Vascular Solutions, Inc., Eufoton S.R.L, Energist Group, Medtronic plc, Dornier MedTech GmbH, Lumenis Ltd., Syneron Medical Ltd., Biolitec AG, and AngioDynamics, Inc.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Varicose Veins Treatment Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
• 3.4. Varicose Veins Treatment Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. Varicose Veins Treatment Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Varicose Veins Treatment Market: Type Movement Analysis, 2023 & 2030 (USD Million)
• 4.3. Endovenous Ablation (EVLA)
  • 4.3.1. Endovenous Ablation (EVLA) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.2. Radiofrequency Ablation
    • 4.3.2.1. Radiofrequency Ablation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.3. Laser Ablation
    • 4.3.3.1. Laser Ablation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Injection Sclerotherapy
  • 4.4.1. Injection Sclerotherapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Surgical Ligation/Stripping
  • 4.5.1. Surgical Ligation/Stripping Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Varicose Veins Treatment Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Varicose Veins Treatment Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
• 5.3. Hospitals
  • 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Ambulatory Surgical Centers
  • 5.4.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Specialty Clinics
  • 5.5.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Varicose Veins Treatment Market: Regional Estimates & Trend Analysis

• 6.1. Varicose Veins Treatment Market Share, By Region, 2023 & 2030 (USD Million)
• 6.2. North America
  • 6.2.1. North America Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.2. U.S.
    • 6.2.2.1. U.S. Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.3. Canada
    • 6.2.3.1. Canada Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.4. Mexico
    • 6.2.4.1. Mexico Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.3. Europe
  • 6.3.1. Europe Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. UK
    • 6.3.2.1. UK Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.3. Germany
    • 6.3.3.1. Germany Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.4. France
    • 6.3.4.1. France Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.5. Italy
    • 6.3.5.1. Italy Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.6. Spain
    • 6.3.6.1. Spain Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.7. Denmark
    • 6.3.7.1. Denmark Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.8. Sweden
    • 6.3.8.1. Sweden Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.9. Norway
    • 6.3.9.1. Norway Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Asia Pacific
  • 6.4.1. Asia Pacific Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. Japan
    • 6.4.2.1. Japan Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. China
    • 6.4.3.1. China Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. India
    • 6.4.4.1. India Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.5. Australia
    • 6.4.5.1. Australia Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.6. Thailand
    • 6.4.6.1. Thailand Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.7. South Korea
    • 6.4.7.1. South Korea Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Latin America
  • 6.5.1. Latin America Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. Brazil
    • 6.5.2.1. Brazil Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Argentina
    • 6.5.3.1. Argentina Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Middle East and Africa
  • 6.6.1. Middle East and Africa Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. South Africa
    • 6.6.2.1. South Africa Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. Saudi Arabia
    • 6.6.3.1. Saudi Arabia Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. UAE
    • 6.6.4.1. UAE Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. Kuwait
    • 6.6.5.1. Kuwait Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis by Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Heat Map Analysis
• 7.4. Company Profiles
  • 7.4.1. Medtronic
    • 7.4.1.1. Participant's Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Recent Developments/ Strategic Initiatives
  • 7.4.2. Lumenis Be Ltd.
    • 7.4.2.1. Participant's Overview
    • 7.4.2.2. Financial Performance
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Recent Developments/ Strategic Initiatives
  • 7.4.3. AngioDynamics
    • 7.4.3.1. Participant's Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Recent Developments/ Strategic Initiatives
  • 7.4.4. Sciton
    • 7.4.4.1. Participant's Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Product Benchmarking
    • 7.4.4.4. Recent Developments/ Strategic Initiatives
  • 7.4.5. Quanta System
    • 7.4.5.1. Participant's Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Product Benchmarking
    • 7.4.5.4. Recent Developments/ Strategic Initiatives
  • 7.4.6. intros Medical Laser GmbH
    • 7.4.6.1. Participant's Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Recent Developments/ Strategic Initiatives
  • 7.4.7. Alma lasers
    • 7.4.7.1. Participant's Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Recent Developments/ Strategic Initiatives
  • 7.4.8. Dornier MedTech
    • 7.4.8.1. Participant's Overview
    • 7.4.8.2. Financial Performance
    • 7.4.8.3. Product Benchmarking
    • 7.4.8.4. Recent Developments/ Strategic Initiatives
  • 7.4.9. Theraclion
    • 7.4.9.1. Participant's Overview
    • 7.4.9.2. Financial Performance
    • 7.4.9.3. Product Benchmarking
    • 7.4.9.4. Recent Developments/ Strategic Initiatives